has received U.S. FDA approval for Pilocarpine Hydrochloride Ophthalmic Solution USP in 1%, 2%, and 4% concentrations, each in 15 mL packages. This approval allows the company to market these eye drops in the United States, potentially opening new revenue streams. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.